{"name": "CeNeRx BioPharma",
 "permalink": "cenerx-biopharma",
 "crunchbase_url": "http://www.crunchbase.com/company/cenerx-biopharma",
 "homepage_url": "http://www.cenerx.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@cenerx.com",
 "phone_number": "(919) 234-4072",
 "description": "",
 "created_at": "Sat Aug 14 01:50:59 UTC 2010",
 "updated_at": "Fri Feb 03 11:10:19 UTC 2012",
 "overview": "\u003Cp\u003ECeNeRx BioPharma, Inc., a drug development company, engages in identifying, developing, and commercializing therapeutics to treat diseases related to neurotransmitters and the nervous system. The company\u00e2\u20ac\u2122s product pipeline includes Tyrima, CX2614, and CX009, which are reversible inhibitors of monoamine oxidase- A that are used for the treatment of mood, anxiety, and somatic disorders. It focuses on developing therapeutics to treat diseases related to neurotransmitters, including anxiety, bipolar disorder, dementia, depression, epilepsy, neuropathic pain, schizophrenia, and Parkinson\u0026#8217;s and Alzheimer\u0026#8217;s diseases. The company was founded in 2005 and is based in Cary, North Carolina.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       90],
      "assets/images/resized/0009/7652/97652v1-max-150x150.jpg"],
     [[200,
       120],
      "assets/images/resized/0009/7652/97652v1-max-250x250.jpg"],
     [[200,
       120],
      "assets/images/resized/0009/7652/97652v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO \u0026 Director",
    "person":
     {"first_name": "Barry",
      "last_name": "Brand",
      "permalink": "barry-brand",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0027/5041/275041v1-max-150x150.jpg"],
          [[200,
            200],
           "assets/images/resized/0027/5041/275041v1-max-250x250.jpg"],
          [[200,
            200],
           "assets/images/resized/0027/5041/275041v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "COO",
    "person":
     {"first_name": "James",
      "last_name": "Free",
      "permalink": "james-free",
      "image": null}},
   {"is_past": false,
    "title": "President \u0026 Director",
    "person":
     {"first_name": "Mark",
      "last_name": "Baric",
      "permalink": "mark-baric",
      "image": null}},
   {"is_past": false,
    "title": "Member of Board",
    "person":
     {"first_name": "Artthur",
      "last_name": "M. Pappas",
      "permalink": "artthur-m-pappas",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0026/7047/267047v1-max-150x150.jpg"],
          [[200,
            200],
           "assets/images/resized/0026/7047/267047v1-max-250x250.jpg"],
          [[200,
            200],
           "assets/images/resized/0026/7047/267047v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$17.6M",
 "funding_rounds":
  [{"round_code": "c",
    "source_url": "http://www.cenerx.com/News/releases/13-AUG-10.pdf",
    "source_description": "CENERX BIOPHARMA COMPLETES $13 MILLION SERIES C FINANCING",
    "raised_amount": 13000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 8,
    "funded_day": 13,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Perseus",
         "permalink": "perseus",
         "image":
          {"available_sizes":
            [[[150,
               13],
              "assets/images/resized/0005/4753/54753v1-max-150x150.png"],
             [[250,
               22],
              "assets/images/resized/0005/4753/54753v1-max-250x250.png"],
             [[446,
               41],
              "assets/images/resized/0005/4753/54753v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "L Capital Partners",
         "permalink": "l-capital-partners",
         "image":
          {"available_sizes":
            [[[150,
               41],
              "assets/images/resized/0002/9187/29187v1-max-150x150.png"],
             [[250,
               68],
              "assets/images/resized/0002/9187/29187v1-max-250x250.png"],
             [[265,
               73],
              "assets/images/resized/0002/9187/29187v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Pappas Ventures",
         "permalink": "pappas-ventures",
         "image":
          {"available_sizes":
            [[[150,
               131],
              "assets/images/resized/0004/9245/49245v1-max-150x150.png"],
             [[164,
               144],
              "assets/images/resized/0004/9245/49245v1-max-250x250.png"],
             [[164,
               144],
              "assets/images/resized/0004/9245/49245v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "d",
    "source_url": "http://onbiovc.com/cenerx-biopharma-inc-series-d-46m/",
    "source_description": "CeNeRx BioPharma, Inc.: Series D $4.6M",
    "raised_amount": 4600000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 2,
    "funded_day": 3,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Aisling Capital",
         "permalink": "aisling-capital",
         "image":
          {"available_sizes":
            [[[150,
               56],
              "assets/images/resized/0004/6625/46625v1-max-150x150.png"],
             [[159,
               60],
              "assets/images/resized/0004/6625/46625v1-max-250x250.png"],
             [[159,
               60],
              "assets/images/resized/0004/6625/46625v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "L Capital Partners",
         "permalink": "l-capital-partners",
         "image":
          {"available_sizes":
            [[[150,
               41],
              "assets/images/resized/0002/9187/29187v1-max-150x150.png"],
             [[250,
               68],
              "assets/images/resized/0002/9187/29187v1-max-250x250.png"],
             [[265,
               73],
              "assets/images/resized/0002/9187/29187v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Pappas Ventures",
         "permalink": "pappas-ventures",
         "image":
          {"available_sizes":
            [[[150,
               131],
              "assets/images/resized/0004/9245/49245v1-max-150x150.png"],
             [[164,
               144],
              "assets/images/resized/0004/9245/49245v1-max-250x250.png"],
             [[164,
               144],
              "assets/images/resized/0004/9245/49245v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "270 Cornerstone Drive",
    "address2": "Suite 103",
    "zip_code": "27519",
    "city": "Cary",
    "state_code": "NC",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}